Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-021757
Filing Date
2017-05-22
Accepted
2017-05-22 17:00:29
Documents
1
Period of Report
2017-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 5779
  Complete submission text file 0001140361-17-021757.txt   7168
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O 99 HAYDEN AVE 1 LEDGEMONT CENTER LEXINGTON MA 02173
Business Address
COOPER GLENN L MD (Reporting) CIK: 0001046351 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 17861649